Cambridge Medical Robotics, fresh from the unveiling of its Versius robot-assisted surgical arm, said today that it added $26 million to the Series A round it plans to use on validation studies and further production.
Existing backers Cambridge Innovation Capital, LGT Global Invest, Escala Capital and ABB Technology Ventures were joined by new investor Watrium in the round’s second tranche, taking the Series A total to $46 million, the Cambridge, U.K.-based company said.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.